[at Seeking Alpha] - The last couple of days have been pretty interesting for the investors of Celldex Therapeutics ( CLDX ). The company has not only announced positive trial data for CDX-1127 but also third quarter results. ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment